News

Deal Announcements

Brickell Biotech Closes $7 Million VC Round

Thursday, February 28, 2013 5:34:00 AM PDT | VentureDeal
   Miami, Florida  --  Brickell Biotech has secured $7 million in new venture capital investment.

Brickell is developing first in class therapeutics for unmet human needs in global dermatology markets.

AMOREPACIFIC Ventures led the round, which also included Palisade Capital Management.

The company said it would use the funding proceeds to support the development of its lead product candidates.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1